Report Cover

Global Sustained Release Injectables Sales Market Report 2021


The global Sustained Release Injectables market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sustained Release Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
    Naltrexone
    Exenatide
    Estradiol
    Other

Segment by Application
    Diabetes
    Leukemia
    Acromegaly
    Other

The Sustained Release Injectables market is analysed and market size information is provided by regions (countries). Segment by Application, the Sustained Release Injectables market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
    AstraZeneca
    Eli Lilly
    Sanofi
    Roche
    Novartis
    Aurobindo
    Avadel
    Biomarin
    Camurus
    Critical Pharmaceuticals
    Alkermes
    Amylin
    Ascendis Pharma
    Taiwan Liposome Company
1 Sustained Release Injectables Market Overview
    1.1 Sustained Release Injectables Product Scope
    1.2 Sustained Release Injectables Segment by Type
        1.2.1 Global Sustained Release Injectables Sales by Type (2016 & 2021 & 2027)
        1.2.2 Naltrexone
        1.2.3 Exenatide
        1.2.4 Estradiol
        1.2.5 Other
    1.3 Sustained Release Injectables Segment by Application
        1.3.1 Global Sustained Release Injectables Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Diabetes
        1.3.3 Leukemia
        1.3.4 Acromegaly
        1.3.5 Other
    1.4 Sustained Release Injectables Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Sustained Release Injectables Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Sustained Release Injectables Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Sustained Release Injectables Price Trends (2016-2027)

2 Sustained Release Injectables Estimates and Forecasts by Region
    2.1 Global Sustained Release Injectables Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Sustained Release Injectables Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
        2.2.2 Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
    2.3 Global Sustained Release Injectables Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Sustained Release Injectables Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Sustained Release Injectables Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.2 Europe Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.3 China Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.4 Japan Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Sustained Release Injectables Estimates and Projections (2016-2027)
        2.4.6 India Sustained Release Injectables Estimates and Projections (2016-2027)
3 Global Sustained Release Injectables Competition Landscape by Players
    3.1 Global Top Sustained Release Injectables Players by Sales (2016-2021)
    3.2 Global Top Sustained Release Injectables Players by Revenue (2016-2021)
    3.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2020)
    3.4 Global Sustained Release Injectables Average Price by Company (2016-2021)
    3.5 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Sustained Release Injectables Market Size by Type
    4.1 Global Sustained Release Injectables Historic Market Review by Type (2016-2021)
        4.1.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
        4.1.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
        4.1.3 Global Sustained Release Injectables Price by Type (2016-2021)
    4.2 Global Sustained Release Injectables Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
        4.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2022-2027)
        4.2.3 Global Sustained Release Injectables Price Forecast by Type (2022-2027)
5 Global Sustained Release Injectables Market Size by Application
    5.1 Global Sustained Release Injectables Historic Market Review by Application (2016-2021)
        5.1.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
        5.1.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
        5.1.3 Global Sustained Release Injectables Price by Application (2016-2021)
    5.2 Global Sustained Release Injectables Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
        5.2.2 Global Sustained Release Injectables Revenue Forecast by Application (2022-2027)
        5.2.3 Global Sustained Release Injectables Price Forecast by Application (2022-2027)

6 North America Sustained Release Injectables Market Facts & Figures
    6.1 North America Sustained Release Injectables Sales by Company
        6.1.1 North America Sustained Release Injectables Sales by Company (2016-2021)
        6.1.2 North America Sustained Release Injectables Revenue by Company (2016-2021)
    6.2 North America Sustained Release Injectables Sales Breakdown by Type
        6.2.1 North America Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        6.2.2 North America Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    6.3 North America Sustained Release Injectables Sales Breakdown by Application
        6.3.1 North America Sustained Release Injectables Sales Breakdown by Application (2016-2021)
        6.3.2 North America Sustained Release Injectables Sales Breakdown by Application (2022-2027)

7 Europe Sustained Release Injectables Market Facts & Figures
    7.1 Europe Sustained Release Injectables Sales by Company
        7.1.1 Europe Sustained Release Injectables Sales by Company (2016-2021)
        7.1.2 Europe Sustained Release Injectables Revenue by Company (2016-2021)
    7.2 Europe Sustained Release Injectables Sales Breakdown by Type
        7.2.1 Europe Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    7.3 Europe Sustained Release Injectables Sales Breakdown by Application
        7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Sustained Release Injectables Market Facts & Figures
    8.1 China Sustained Release Injectables Sales by Company
        8.1.1 China Sustained Release Injectables Sales by Company (2016-2021)
        8.1.2 China Sustained Release Injectables Revenue by Company (2016-2021)
    8.2 China Sustained Release Injectables Sales Breakdown by Type
        8.2.1 China Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        8.2.2 China Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    8.3 China Sustained Release Injectables Sales Breakdown by Application
        8.3.1 China 314 Sales Breakdown by Application (2016-2021)
        8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Sustained Release Injectables Market Facts & Figures
    9.1 Japan Sustained Release Injectables Sales by Company
        9.1.1 Japan Sustained Release Injectables Sales by Company (2016-2021)
        9.1.2 Japan Sustained Release Injectables Revenue by Company (2016-2021)
    9.2 Japan Sustained Release Injectables Sales Breakdown by Type
        9.2.1 Japan Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    9.3 Japan Sustained Release Injectables Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sustained Release Injectables Market Facts & Figures
    10.1 Southeast Asia Sustained Release Injectables Sales by Company
        10.1.1 Southeast Asia Sustained Release Injectables Sales by Company (2016-2021)
        10.1.2 Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021)
    10.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type
        10.2.1 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Sustained Release Injectables Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Sustained Release Injectables Market Facts & Figures
    11.1 India Sustained Release Injectables Sales by Company
        11.1.1 India Sustained Release Injectables Sales by Company (2016-2021)
        11.1.2 India Sustained Release Injectables Revenue by Company (2016-2021)
    11.2 India Sustained Release Injectables Sales Breakdown by Type
        11.2.1 India Sustained Release Injectables Sales Breakdown by Type (2016-2021)
        11.2.2 India Sustained Release Injectables Sales Breakdown by Type (2022-2027)
    11.3 India Sustained Release Injectables Sales Breakdown by Application
        11.3.1 India Sustained Release Injectables Sales Breakdown by Application (2016-2021)
        11.3.2 India Sustained Release Injectables Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sustained Release Injectables Business
    12.1 AstraZeneca
        12.1.1 AstraZeneca Corporation Information
        12.1.2 AstraZeneca Business Overview
        12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 AstraZeneca Sustained Release Injectables Products Offered
        12.1.5 AstraZeneca Recent Development
    12.2 Eli Lilly
        12.2.1 Eli Lilly Corporation Information
        12.2.2 Eli Lilly Business Overview
        12.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Eli Lilly Sustained Release Injectables Products Offered
        12.2.5 Eli Lilly Recent Development
    12.3 Sanofi
        12.3.1 Sanofi Corporation Information
        12.3.2 Sanofi Business Overview
        12.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Sanofi Sustained Release Injectables Products Offered
        12.3.5 Sanofi Recent Development
    12.4 Roche
        12.4.1 Roche Corporation Information
        12.4.2 Roche Business Overview
        12.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Roche Sustained Release Injectables Products Offered
        12.4.5 Roche Recent Development
    12.5 Novartis
        12.5.1 Novartis Corporation Information
        12.5.2 Novartis Business Overview
        12.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Novartis Sustained Release Injectables Products Offered
        12.5.5 Novartis Recent Development
    12.6 Aurobindo
        12.6.1 Aurobindo Corporation Information
        12.6.2 Aurobindo Business Overview
        12.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Aurobindo Sustained Release Injectables Products Offered
        12.6.5 Aurobindo Recent Development
    12.7 Avadel
        12.7.1 Avadel Corporation Information
        12.7.2 Avadel Business Overview
        12.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Avadel Sustained Release Injectables Products Offered
        12.7.5 Avadel Recent Development
    12.8 Biomarin
        12.8.1 Biomarin Corporation Information
        12.8.2 Biomarin Business Overview
        12.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Biomarin Sustained Release Injectables Products Offered
        12.8.5 Biomarin Recent Development
    12.9 Camurus
        12.9.1 Camurus Corporation Information
        12.9.2 Camurus Business Overview
        12.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Camurus Sustained Release Injectables Products Offered
        12.9.5 Camurus Recent Development
    12.10 Critical Pharmaceuticals
        12.10.1 Critical Pharmaceuticals Corporation Information
        12.10.2 Critical Pharmaceuticals Business Overview
        12.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered
        12.10.5 Critical Pharmaceuticals Recent Development
    12.11 Alkermes
        12.11.1 Alkermes Corporation Information
        12.11.2 Alkermes Business Overview
        12.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Alkermes Sustained Release Injectables Products Offered
        12.11.5 Alkermes Recent Development
    12.12 Amylin
        12.12.1 Amylin Corporation Information
        12.12.2 Amylin Business Overview
        12.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Amylin Sustained Release Injectables Products Offered
        12.12.5 Amylin Recent Development
    12.13 Ascendis Pharma
        12.13.1 Ascendis Pharma Corporation Information
        12.13.2 Ascendis Pharma Business Overview
        12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Ascendis Pharma Sustained Release Injectables Products Offered
        12.13.5 Ascendis Pharma Recent Development
    12.14 Taiwan Liposome Company
        12.14.1 Taiwan Liposome Company Corporation Information
        12.14.2 Taiwan Liposome Company Business Overview
        12.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Taiwan Liposome Company Sustained Release Injectables Products Offered
        12.14.5 Taiwan Liposome Company Recent Development

13 Sustained Release Injectables Manufacturing Cost Analysis
    13.1 Sustained Release Injectables Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Sustained Release Injectables
    13.4 Sustained Release Injectables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Sustained Release Injectables Distributors List
    14.3 Sustained Release Injectables Customers

15 Market Dynamics
    15.1 Sustained Release Injectables Market Trends
    15.2 Sustained Release Injectables Drivers
    15.3 Sustained Release Injectables Market Challenges
    15.4 Sustained Release Injectables Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer

List of Tables Table 1. Global Sustained Release Injectables Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Sustained Release Injectables Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Sustained Release Injectables Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Sustained Release Injectables Sales (K Units) by Region (2016-2021) Table 5. Global Sustained Release Injectables Sales Market Share by Region (2016-2021) Table 6. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Sustained Release Injectables Revenue Share by Region (2016-2021) Table 8. Global Sustained Release Injectables Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Sustained Release Injectables Sales Market Share Forecast by Region (2022-2027) Table 10. Global Sustained Release Injectables Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Sustained Release Injectables Revenue Share Forecast by Region (2022-2027) Table 12. Global Sustained Release Injectables Sales (K Units) of Key Companies (2016-2021) Table 13. Global Sustained Release Injectables Sales Share by Company (2016-2021) Table 14. Global Sustained Release Injectables Revenue (US$ Million) by Company (2016-2021) Table 15. Global Sustained Release Injectables Revenue Share by Company (2016-2021) Table 16. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2020) Table 17. Global Sustained Release Injectables Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Sustained Release Injectables Manufacturing Sites and Area Served Table 19. Manufacturers Sustained Release Injectables Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Sustained Release Injectables Sales (K Units) by Type (2016-2021) Table 22. Global Sustained Release Injectables Sales Share by Type (2016-2021) Table 23. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Sustained Release Injectables Price (USD/Unit) by Type (2016-2021) Table 25. Global Sustained Release Injectables Sales Share by Type (2022-2027) Table 26. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Sustained Release Injectables Revenue Share by Type (2022-2027) Table 28. Global Sustained Release Injectables Price (USD/Unit) by Type (2022-2027) Table 29. Global Sustained Release Injectables Sales (K Units) by Application (2016-2021) Table 30. Global Sustained Release Injectables Sales Share by Application (2016-2021) Table 31. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Sustained Release Injectables Price (USD/Unit) by Application (2016-2021) Table 33. Global Sustained Release Injectables Sales (K Units) by Application (2022-2027) Table 34. Global Sustained Release Injectables Sales Share by Application (2022-2027) Table 35. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Sustained Release Injectables Revenue Share by Application (2022-2027) Table 37. Global Sustained Release Injectables Price (USD/Unit) by Application (2022-2027) Table 38. North America Sustained Release Injectables Sales (K Units) by Company (2016-2021) Table 39. North America Sustained Release Injectables Sales Market Share by Company (2016-2021) Table 40. North America Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Sustained Release Injectables Revenue Market Share by Company (2016-2021) Table 42. North America Sustained Release Injectables Sales by Type (2016-2021) & (K Units) Table 43. North America Sustained Release Injectables Sales Market Share by Type (2016-2021) Table 44. North America Sustained Release Injectables Sales by Type (2022-2027) & (K Units) Table 45. North America Sustained Release Injectables Sales Market Share by Type (2022-2027) Table 46. North America Sustained Release Injectables Sales by Application (2016-2021) & (K Units) Table 47. North America Sustained Release Injectables Sales Market Share by Application (2016-2021) Table 48. North America Sustained Release Injectables Sales by Application (2022-2027) & (K Units) Table 49. North America Sustained Release Injectables Sales Market Share by Application (2022-2027) Table 50. Europe Sustained Release Injectables Sales (K Units) by Company (2016-2021) Table 51. Europe Sustained Release Injectables Sales Market Share by Company (2016-2021) Table 52. Europe Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Sustained Release Injectables Revenue Market Share by Company (2016-2021) Table 54. Europe Sustained Release Injectables Sales by Type (2016-2021) & (K Units) Table 55. Europe Sustained Release Injectables Sales Market Share by Type (2016-2021) Table 56. Europe Sustained Release Injectables Sales by Type (2022-2027) & (K Units) Table 57. Europe Sustained Release Injectables Sales Market Share by Type (2022-2027) Table 58. Europe Sustained Release Injectables Sales by Application (2016-2021) & (K Units) Table 59. Europe Sustained Release Injectables Sales Market Share by Application (2016-2021) Table 60. Europe Sustained Release Injectables Sales by Application (2022-2027) & (K Units) Table 61. Europe Sustained Release Injectables Sales Market Share by Application (2022-2027) Table 62. China Sustained Release Injectables Sales (K Units) by Company (2016-2021) Table 63. China Sustained Release Injectables Sales Market Share by Company (2016-2021) Table 64. China Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million) Table 65. China Sustained Release Injectables Revenue Market Share by Company (2016-2021) Table 66. China Sustained Release Injectables Sales by Type (2016-2021) & (K Units) Table 67. China Sustained Release Injectables Sales Market Share by Type (2016-2021) Table 68. China Sustained Release Injectables Sales by Type (2022-2027) & (K Units) Table 69. China Sustained Release Injectables Sales Market Share by Type (2022-2027) Table 70. China Sustained Release Injectables Sales by Application (2016-2021) & (K Units) Table 71. China Sustained Release Injectables Sales Market Share by Application (2016-2021) Table 72. China Sustained Release Injectables Sales by Application (2022-2027) & (K Units) Table 73. China Sustained Release Injectables Sales Market Share by Application (2022-2027) Table 74. Japan Sustained Release Injectables Sales (K Units) by Company (2016-2021) Table 75. Japan Sustained Release Injectables Sales Market Share by Company (2016-2021) Table 76. Japan Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Sustained Release Injectables Revenue Market Share by Company (2016-2021) Table 78. Japan Sustained Release Injectables Sales by Type (2016-2021) & (K Units) Table 79. Japan Sustained Release Injectables Sales Market Share by Type (2016-2021) Table 80. Japan Sustained Release Injectables Sales by Type (2022-2027) & (K Units) Table 81. Japan Sustained Release Injectables Sales Market Share by Type (2022-2027) Table 82. Japan Sustained Release Injectables Sales by Application (2016-2021) & (K Units) Table 83. Japan Sustained Release Injectables Sales Market Share by Application (2016-2021) Table 84. Japan Sustained Release Injectables Sales by Application (2022-2027) & (K Units) Table 85. Japan Sustained Release Injectables Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Sustained Release Injectables Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Sustained Release Injectables Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Sustained Release Injectables Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Sustained Release Injectables Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Sustained Release Injectables Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Sustained Release Injectables Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Sustained Release Injectables Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2022-2027) Table 98. India Sustained Release Injectables Sales (K Units) by Company (2016-2021) Table 99. India Sustained Release Injectables Sales Market Share by Company (2016-2021) Table 100. India Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million) Table 101. India Sustained Release Injectables Revenue Market Share by Company (2016-2021) Table 102. India Sustained Release Injectables Sales by Type (2016-2021) & (K Units) Table 103. India Sustained Release Injectables Sales Market Share by Type (2016-2021) Table 104. India Sustained Release Injectables Sales by Type (2022-2027) & (K Units) Table 105. India Sustained Release Injectables Sales Market Share by Type (2022-2027) Table 106. India Sustained Release Injectables Sales by Application (2016-2021) & (K Units) Table 107. India Sustained Release Injectables Sales Market Share by Application (2016-2021) Table 108. India Sustained Release Injectables Sales by Application (2022-2027) & (K Units) Table 109. India Sustained Release Injectables Sales Market Share by Application (2022-2027) Table 110. AstraZeneca Corporation Information Table 111. AstraZeneca Description and Business Overview Table 112. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. AstraZeneca Sustained Release Injectables Product Table 114. AstraZeneca Recent Development Table 115. Eli Lilly Corporation Information Table 116. Eli Lilly Description and Business Overview Table 117. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Eli Lilly Sustained Release Injectables Product Table 119. Eli Lilly Recent Development Table 120. Sanofi Corporation Information Table 121. Sanofi Description and Business Overview Table 122. Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Sanofi Sustained Release Injectables Product Table 124. Sanofi Recent Development Table 125. Roche Corporation Information Table 126. Roche Description and Business Overview Table 127. Roche Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Roche Sustained Release Injectables Product Table 129. Roche Recent Development Table 130. Novartis Corporation Information Table 131. Novartis Description and Business Overview Table 132. Novartis Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Novartis Sustained Release Injectables Product Table 134. Novartis Recent Development Table 135. Aurobindo Corporation Information Table 136. Aurobindo Description and Business Overview Table 137. Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Aurobindo Sustained Release Injectables Product Table 139. Aurobindo Recent Development Table 140. Avadel Corporation Information Table 141. Avadel Description and Business Overview Table 142. Avadel Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Avadel Sustained Release Injectables Product Table 144. Avadel Recent Development Table 145. Biomarin Corporation Information Table 146. Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Biomarin Description and Business Overview Table 148. Biomarin Sustained Release Injectables Product Table 149. Biomarin Recent Development Table 150. Camurus Corporation Information Table 151. Camurus Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Camurus Description and Business Overview Table 153. Camurus Sustained Release Injectables Product Table 154. Camurus Recent Development Table 155. Critical Pharmaceuticals Corporation Information Table 156. Critical Pharmaceuticals Description and Business Overview Table 157. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Critical Pharmaceuticals Sustained Release Injectables Product Table 159. Critical Pharmaceuticals Recent Development Table 160. Alkermes Corporation Information Table 161. Alkermes Description and Business Overview Table 162. Alkermes Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 163. Alkermes Sustained Release Injectables Product Table 164. Alkermes Recent Development Table 165. Amylin Corporation Information Table 166. Amylin Description and Business Overview Table 167. Amylin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 168. Amylin Sustained Release Injectables Product Table 169. Amylin Recent Development Table 170. Ascendis Pharma Corporation Information Table 171. Ascendis Pharma Description and Business Overview Table 172. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 173. Ascendis Pharma Sustained Release Injectables Product Table 174. Ascendis Pharma Recent Development Table 175. Taiwan Liposome Company Corporation Information Table 176. Taiwan Liposome Company Description and Business Overview Table 177. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 178. Taiwan Liposome Company Sustained Release Injectables Product Table 179. Taiwan Liposome Company Recent Development Table 180. Production Base and Market Concentration Rate of Raw Material Table 181. Key Suppliers of Raw Materials Table 182. Sustained Release Injectables Distributors List Table 183. Sustained Release Injectables Customers List Table 184. Sustained Release Injectables Market Trends Table 185. Sustained Release Injectables Market Drivers Table 186. Sustained Release Injectables Market Challenges Table 187. Sustained Release Injectables Market Restraints Table 188. Research Programs/Design for This Report Table 189. Key Data Information from Secondary Sources Table 190. Key Data Information from Primary Sources List of Figures Figure 1. Sustained Release Injectables Product Picture Figure 2. Global Sustained Release Injectables Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Sustained Release Injectables Sales Market Share by Application in 2021 & 2027 Figure 6. Diabetes Examples Figure 7. Leukemia Examples Figure 8. Acromegaly Examples Figure 9. Other Examples Figure 10. Global Sustained Release Injectables Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Sustained Release Injectables Sales Growth Rate (2016-2027) & (US$ Million) Figure 12. Global Sustained Release Injectables Sales (K Units) Growth Rate (2016-2027) Figure 13. Global Sustained Release Injectables Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 14. Global Sustained Release Injectables Revenue Market Share by Region: 2016 VS 2021 Figure 15. Global Sustained Release Injectables Revenue Market Share by Region: 2021 VS 2027 Figure 16. North America Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027) Figure 17. North America Sustained Release Injectables Sales (K Units) Growth Rate (2016-2027) Figure 18. Europe Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027) Figure 19. Europe Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027) Figure 20. China Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027) Figure 21. China Sustained Release Injectables Sales (Million USD) and Growth Rate (2016-2027) Figure 22. Japan Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Japan Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Southeast Asia Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027) Figure 26. India Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027) Figure 27. India Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027) Figure 28. Global 5 Largest Sustained Release Injectables Players Market Share by Revenue in Sustained Release Injectables: 2016 & 2020 Figure 29. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 30. Global Sustained Release Injectables Revenue Share by Type (2016-2021) Figure 31. Global Sustained Release Injectables Revenue Growth Rate by Type in 2016 & 2020 Figure 32. Global Sustained Release Injectables Revenue Share by Application (2016-2021) Figure 33. Global Sustained Release Injectables Revenue Growth Rate by Application in 2016 & 2020 Figure 34. North America Sustained Release Injectables Sales Market Share by Type in 2020 Figure 35. North America Sustained Release Injectables Sales Market Share by Application in 2020 Figure 36. Europe Sustained Release Injectables Sales Market Share by Type in 2020 Figure 37. Europe Sustained Release Injectables Sales Market Share by Application in 2020 Figure 38. China Sustained Release Injectables Sales Market Share by Type in 2020 Figure 39. China Sustained Release Injectables Sales Market Share by Application in 2020 Figure 40. Japan Sustained Release Injectables Sales Market Share by Type in 2020 Figure 41. Japan Sustained Release Injectables Sales Market Share by Application in 2020 Figure 42. Southeast Asia Sustained Release Injectables Sales Market Share by Type in 2020 Figure 43. Southeast Asia Sustained Release Injectables Sales Market Share by Application in 2020 Figure 44. India Sustained Release Injectables Sales Market Share by Type in 2020 Figure 45. India Sustained Release Injectables Sales Market Share by Application in 2020 Figure 46. Key Raw Materials Price Trend Figure 47. Manufacturing Cost Structure of Sustained Release Injectables Figure 48. Manufacturing Process Analysis of Sustained Release Injectables Figure 49. Sustained Release Injectables Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us